• Nitric Oxide (NO)-releasing wound patch, mimics the natural endogenous release of the human body, and exploits the anti-microbial, anti-inflammatory, and wound repair properties of naturally produced NO.

• NO is an endogenous gas produced by the inner lining of human blood vessels and other immune cells.

• NO has broad antimicrobial activity and no demonstrated resistance.

• NO regulates and promotes all four stages of the wound healing process which progresses in regulated and sequential phases consisting of hemostasis, inflammation, proliferation, and remodeling.

• NO regulates and promotes all four stages of the wound healing process which progresses in regulated and sequential phases consisting of hemostasis, inflammation, proliferation, and remodeling 

• Nytricx is developing a Fiber Optic NO-releasing wound patch, based on it's Fiber Optic catheter insert technology, designed to impact both acute and chronic wound care, without induction of resistance, common with antibiotic drugs. 

​